NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 715973 | Null | 0.00457614317494024 | -0.31495155 |
NSC 716260 | Null | 0.00457614317494024 | -0.17695836 |
NSC 734294 | Indenoisoquinoline derivative | 0.00457614317494024 | -0.20091765 |
NSC 736164 | pyrazoline derivative | 0.00457614317494024 | -0.33131562 |
NSC 740276 | 5,6-Dihydro-6-[3-(hydroxyethyl)amino-1-propyl]-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloide | 0.00457614317494024 | -0.27733766 |
NSC 740504 | 5,6-Dihydro-6-[3-(2-hydroxyethyl)amino-1-propyl]-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride | 0.00457614317494024 | -0.20061712 |
NSC 743862 | Null | 0.00457614317494024 | -0.38900037 |
NSC 744331 | (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd | 0.00457614317494024 | -0.28778797 |
NSC 756169 | GSK317314A | 0.00457614317494024 | -0.4078652 |
NSC 758664 | Sirolimus [USAN] | 0.00457614317494024 | 0.24184418 |